AU641991B2 - Novel insulin compositions - Google Patents

Novel insulin compositions

Info

Publication number: AU641991B2
Authority: AU; Australia
Prior art keywords: insulin; iii; ins; general formula; pharmaceutical composition
Prior art date: 1990-02-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

AU73378/91A

Other languages

English (en)

Other versions

AU7337891A (en

Inventor

Jorgen Frederik Hansen

Ulla Ribel-Madsen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novo Nordisk AS

Original Assignee

Novo Nordisk AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-21

Filing date

1991-02-21

Publication date

1993-10-07

1991-02-21 Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS

1991-09-18 Publication of AU7337891A publication Critical patent/AU7337891A/en

1993-10-07 Application granted granted Critical

1993-10-07 Publication of AU641991B2 publication Critical patent/AU641991B2/en

2011-02-21 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Chairs For Special Purposes, Such As Reclining Chairs (AREA)

AU73378/91A 1990-02-21 1991-02-21 Novel insulin compositions Expired - Fee Related AU641991B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK455/90		1990-02-21
DK045590A DK45590D0 (2)	1990-02-21	1990-02-21

Publications (2)

Publication Number	Publication Date
AU7337891A AU7337891A (en)	1991-09-18
AU641991B2 true AU641991B2 (en)	1993-10-07

Family

ID=8093754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU73378/91A Expired - Fee Related AU641991B2 (en)	1990-02-21	1991-02-21	Novel insulin compositions

Country Status (12)

Country	Link
EP (1)	EP0516704B1 (2)
JP (1)	JPH05503940A (2)
AU (1)	AU641991B2 (2)
CA (1)	CA2075982A1 (2)
DE (1)	DE69100626D1 (2)
DK (1)	DK45590D0 (2)
HU (1)	HUT63858A (2)
IE (1)	IE910579A1 (2)
NZ (1)	NZ237176A (2)
PT (1)	PT96841A (2)
WO (1)	WO1991012817A1 (2)
ZA (1)	ZA911279B (2)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9316895D0 (en) *	1993-08-13	1993-09-29	Guy S And St Thomas Hospitals	Hepatoselective insulin analogues
US6342225B1 (en)	1993-08-13	2002-01-29	Deutshces Wollforschungsinstitut	Pharmaceutical active conjugates
US6011007A (en) *	1993-09-17	2000-01-04	Novo Nordisk A/S	Acylated insulin
SI0792290T1 (en) *	1993-09-17	2001-12-31	Novo Nordisk As	Acylated insulin
US6869930B1 (en)	1993-09-17	2005-03-22	Novo Nordisk A/S	Acylated insulin
US6251856B1 (en)	1995-03-17	2001-06-26	Novo Nordisk A/S	Insulin derivatives
US6451762B1 (en)	1997-10-24	2002-09-17	Novo Nordisk A/S	Aggregates of human insulin derivatives
ES2472421T3 (es)	2003-08-05	2014-07-01	Novo Nordisk A/S	Nuevos derivados de insulina
EP2107069B1 (en)	2003-08-05	2013-01-16	Novo Nordisk A/S	Novel insulin derivatives
ES2438145T3 (es)	2005-02-02	2014-01-16	Novo Nordisk A/S	Nuevos derivados de insulina
US20090074882A1 (en)	2005-12-28	2009-03-19	Novo Nordisk A/S	Insulin compositions and method of making a composition
JP5550338B2 (ja)	2006-07-31	2014-07-16	ノボ・ノルデイスク・エー／エス	ペグ化持続型インスリン
HUE029512T2 (en)	2006-09-22	2017-03-28	Novo Nordisk As	Protease Resistant Insulin Analogs
JP5496082B2 (ja)	2007-04-30	2014-05-21	ノボ・ノルデイスク・エー／エス	タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5552046B2 (ja)	2007-06-13	2014-07-16	ノボ・ノルデイスク・エー／エス	インスリン誘導体を含有する薬学的製剤
JP5762001B2 (ja)	2008-03-14	2015-08-12	ノボ・ノルデイスク・エー／エス	プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en)	2008-03-18	2009-09-24	Novo Nordisk A/S	Protease stabilized, acylated insulin analogues
KR20110085985A (ko)	2008-10-30	2011-07-27	노보 노르디스크 에이/에스	하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
BR112013010345A2 (pt)	2010-10-27	2017-07-25	Novo Nordisk As	tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
CA2870313A1 (en)	2012-04-11	2013-10-17	Novo Nordisk A/S	Insulin formulations
JP2016519127A (ja)	2013-04-30	2016-06-30	ノヴォノルディスクアー／エス	新規投与レジメン
AU2014333979B2 (en)	2013-10-07	2018-02-15	Novo Nordisk A/S	Novel derivative of an insulin analogue
ES2886837T3 (es)	2016-12-16	2021-12-21	Novo Nordisk As	Composiciones farmacéuticas que contienen insulina
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
US12343383B2 (en)	2019-07-12	2025-07-01	Novo Nordisk A/S	High concentration insulin formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE971500C (de) *	1950-11-22	1959-02-05	Organon Nv	Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung
DE1107374B (de) *	1958-01-31	1961-05-25	Organon Nv	Verfahren zur Herstellung eines Insulin-Praeparates

1990
- 1990-02-21 DK DK045590A patent/DK45590D0/da not_active Application Discontinuation
1991
- 1991-02-20 IE IE057991A patent/IE910579A1/en unknown
- 1991-02-20 NZ NZ237176A patent/NZ237176A/en unknown
- 1991-02-21 JP JP3504590A patent/JPH05503940A/ja active Pending
- 1991-02-21 ZA ZA911279A patent/ZA911279B/xx unknown
- 1991-02-21 HU HU922721Q patent/HUT63858A/hu unknown
- 1991-02-21 PT PT96841A patent/PT96841A/pt not_active Application Discontinuation
- 1991-02-21 DE DE91904980T patent/DE69100626D1/de not_active Expired - Lifetime
- 1991-02-21 CA CA002075982A patent/CA2075982A1/en not_active Abandoned
- 1991-02-21 AU AU73378/91A patent/AU641991B2/en not_active Expired - Fee Related
- 1991-02-21 EP EP91904980A patent/EP0516704B1/en not_active Expired - Lifetime
- 1991-02-21 WO PCT/DK1991/000052 patent/WO1991012817A1/en not_active Ceased

Also Published As

Publication number	Publication date
ZA911279B (en)	1991-10-30
JPH05503940A (ja)	1993-06-24
IE910579A1 (en)	1991-08-28
HUT63858A (en)	1993-10-28
DK45590D0 (2)	1990-02-21
NZ237176A (en)	1991-12-23
PT96841A (pt)	1991-11-29
DE69100626D1 (de)	1993-12-16
CA2075982A1 (en)	1991-08-22
HU9202721D0 (en)	1992-12-28
WO1991012817A1 (en)	1991-09-05
EP0516704A1 (en)	1992-12-09
EP0516704B1 (en)	1993-11-10
AU7337891A (en)	1991-09-18

Publication	Publication Date	Title
AU7337891A (en)	1991-09-18	Novel insulin compositions
DE3885317T2 (de)	1994-03-03	Makromolekulare Platin-Antitumorverbindungen.
DE3780218T2 (de)	1992-12-17	Tumor-nekrose-faktor-formulierung und ihre herstellung.
Mahmood et al.	2005	Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
DE3880346T2 (de)	1993-07-29	Insulinderivate.
US5456922A (en)	1995-10-10	Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
AU608584B2 (en)	1991-04-11	Stable interferon complexes
KR890004687B1 (ko)	1989-11-25	생물학적 활성 서방출성 조성물
EP2943216B1 (en)	2019-05-01	Modified ace2 polypeptides
HU227992B1 (en)	2012-08-28	Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them
AU2008261591A1 (en)	2008-12-18	ACE2 polypeptide
CZ85790A3 (en)	1995-02-15	Novel preparations containing associates of hyaluronic acid, and process for preparing thereof
JP2003530361A (ja)	2003-10-14	化学的に修飾した新規なエリスロポエチン刺激タンパク質組成物および方法
EP2496213B1 (en)	2015-08-12	Pharmaceutical solution of non covalently bound albumin and acylated insulin
KR20050090430A (ko)	2005-09-13	인간 성장 호르몬 결정 및 이것의 제조 방법
ZA200600846B (en)	2007-04-25	Novel insulin derivatives
CN109069590A (zh)	2018-12-21	包含聚山梨酯80的胰岛素制剂
JPH04504117A (ja)	1992-07-23	グリコシル化インシュリン
IE42395B1 (en)	1980-07-30	Production of long acting insulin preparations
JPH10511365A (ja)	1998-11-04	遅延性ｇｌｐ−１組成物
EP1301075B1 (en)	2008-04-02	Modified serum albumin with reduced affinity for nickel and copper
EP0119650A2 (en)	1984-09-26	Galactosyl-insulin conjugates useful in treating diabetics
US5028587A (en)	1991-07-02	Mixed crystals of insulin and insulin derivatives
AU2009218835B2 (en)	2012-08-23	Selenium containing modifying agents and conjugates
US6451762B1 (en)	2002-09-17	Aggregates of human insulin derivatives